As of press release, according to incomplete statistics, 17 A-share listed companies, including Tiger Pharmaceuticals, Kangyuan Pharmaceutical, China Software, Japan Union Technology, Guangpu, Zhendong Pharmaceutical, Qingniao Fire, Heltai, Yaxia, Shede Liquor, Suwen Electric, Dian Diagnostics, Jiansheng Group, Pinneng Technology, Zhaoyi Innovation, Donggang Co., Ltd., and Pengyao Environmental Protection disclosed plans with a repurchase limit of 200 million yuan. Among them, Tiger Pharmaceuticals plans to repurchase shares of 500 million yuan to 1 billion yuan, involving the largest amount of money. The company will repurchase shares to later implement the A-share incentive plan or A-share employee shareholding plan and reduce the company's registered capital; Zhendong Pharmaceutical plans to buy back 100 million yuan to 200 million yuan of shares to cancel and reduce the registered capital.
近20家上市公司盘后披露回购金额上限达2亿元的计划公告 泰格医药拟5-10亿元回购
Nearly 20 listed companies announced plans with a maximum repurchase amount of 200 million yuan after the market, and Tiger Pharmaceuticals plans to buy back 5-10 billion yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.